A systematic review and meta-analysis of eight randomized clinical trials found that silymarin significantly reduces liver enzyme levels, specifically ALT and AST, compared to placebo, even without concurrent weight loss
This includes supporting the cellular structures that maintain internal tissue integrity, helping to manage localized inflammation and promote overall resilience
doi: 10.3389/fimmu.2026.1630969 Received 19 May 2025 Revised 07 February 2026 Accepted 09 February 2026 Published 27 February 2026 Volume 17 - 2026 Edited by Pablo Andres Evelson, University of Buenos Aires, Argentina Reviewed by Huanling Lai, Guangzhou National Laboratory, China Neelima Sharma, Birla Institute of Technology and Science, India Updates Copyright 2026 Ni, Chen, Jiang and Huang
How do injectables work
It's a nonapeptide found in various tissues